Back to Top

Hepatitis C

Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.


The PAN Foundation’s Hepatitis C fund is currently closed. As of June 18, 2018, Healthwell and Good Days are accepting applications.

Assistance Amount

$7,200 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for hepatitis C.
  2. The patient must have health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Copegus (ribavirin)
  • Daklinza (daclatasvir dihydrochloride)
  • Epclusa (sofosbuvir/velpatasvir)
  • Harvoni (ledipasvir/sofosbuvir)
  • Infergen (interferon alfacon-1)
  • Intron A (interferon alfa-2b, recomb.)
  • Mavyret (glecaprevir/pibrentasvir)
  • Moderiba (ribavirin)
  • Olysio (simeprevir sodium)
  • Pegasys (peginterferon alfa-2a)
  • Rebetol (ribavirin)
  • Ribasphere (ribavirin)
  • Ribatab (ribavirin)
  • Ribavirin (ribavirin)
  • Sovaldi (sofosbuvir)
  • Sylatron (peginterferon alfa-2b)
  • Technivie (ombitasvir/paritaprevir/ritonavir)
  • Viekira Xr (ombitasvir/paritaprevir/ritonavir/dasabuvir sodium)
  • Vosevi (sofosbuvir/velpatasvir/voxilaprevir)
  • Xifaxan (rifaximin)
  • Zepatier (elbasvir/grazoprevir)